Prostasin, a potential tumor marker in ovarian cancer - A pilot study

Clinics

Volumn 64, Issue 7, 2009, Pages 641-644

  Costa, Fernanda Pires ^a   Batista Junior, Eraldo Luis ^a   Zelmanowicz, Alice ^b   Svedman, Christer ^c   Devenz, Gabriela ^a   Alves, Silvana ^a   da Silva, Andrea Simões Martins ^c   Garicochea, Bernardo ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Hospital da Santa Casa   (Brazil)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Biomarker; Detection; Diagnostic; PRSS8; Screening

Indexed keywords

PROSTASIN; SERINE PROTEINASE; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BLOOD; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; MASS SCREENING; METHODOLOGY; MIDDLE AGED; OVARY TUMOR; PILOT STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MASS SCREENING; MIDDLE AGED; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PILOT PROJECTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERINE ENDOPEPTIDASES; TUMOR MARKERS, BIOLOGICAL;

EID: 69149098620     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322009000700006     Document Type: Article

References (21)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10-30.
2. Pascalicchio JC, Fristachi CE, Castanho PL, Kue CM, Piato S, Baracat FF. Epidemiologia do câncer de ovário no Brasil. RSBC. 2000;11:46-53.
3. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, et al. SEER Cancer Statistics Review, 1975-2005, National Cancer Institute. Bethesda, MD. 2008.
4. Meyer T, Rustin GJ. Role of tumour markers in monitoring epithelial ovarian cancer. Br J Cancer. 2000;82:1535-8.
5. Bast RC Jr, Xu FJ, Yu YH, Barnhill S, Zhang Z, Mills GB. CA 125: the past and the future. Int J Biol Marker. 1998;13:179-87.
6. Bast RC Jr, Badgwell D, Lu Z, Marquez R, Rosen D, Liu J. New tumor markers: CA125 and beyond. Int J Gynecol Cancer. 2005;15(Suppl 3):274-81.
7. Gagnon A, Ye B. Discovery and application of protein biomarkers for ovarian cancer. Curr Opin Obstet Gynecol. 2008;20:9-13.
8. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 2002;359:572-7.
9. Zhang Z, Yu Y, Xu F, Berchuck A, van Haaften-Day C, Havrilesky LJ. Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer. Gynecol Oncol. 2007;107:526-31.
10. Skates SJ, Horick N, Yu Y, Xu FJ, Berchuck A, Havrilesky LJ. Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions. J Clin Oncol. 2004;22:4059-66.
11. Mok SC, Chao J, Skates S, Wong K, Yiu GK, Muto MG. Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology. J Natl Cancer Inst. 2001;93:1458-64.
12. Li M, Li W, Kim HJ, Yao Q, Chen C, Fisher WE. Characterization of somatostatin receptor expression in human pancreatic cancer using real-time RT-PCR. J Surg Res. 2004;119:130-7.
13. Livak, KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402-8.
14. Yu JX, Chao L, Chao J. Prostasin is a novel human serine proteinase from seminal fluid. Purification, tissue distribution, and localization in prostate gland. J Biol Chem. 1994;269:18843-8.
15. Yu JX, Chao L, Chao J. Molecular cloning, tissue-specific expression, and cellular localization of human prostasin mRNA. J Biol Chem. 1995;270:13483-9.
16. Yu XJ, Chao L, Ward DC, Chao J. Structure and chromossomal localization of the human prostasin (PRSS8) gene. Genomics. 1996;32:334-40.
17. Chen LM, Hodge GB, Guarda LA, Welch JL, Greenberg NM, Chai KX. Down-regulation of prostasin serine protease: a potential invasion suppressor in prostate cancer. Prostate. 2001;48:93-103.
18. Takahashi S, Suzuki S, Inaguma S, Ikeda Y, Cho YM, Hayashi N. Down- regulated expression of prostasin in high-grade or hormone-refractory human prostate cancers. Prostate. 2003;54:187-93.
19. Chen LM, Chai KX. Prostasin serine protease inhibits breast cancer invasiveness and is transcriptionally regulated by promoter DNA methylation. Int J Cancer. 2002;97:323-9.
20. Chen M, Chen LM, Lin CY, Chai KX. The epidermal growth factor receptor (EGFR) is proteolytically modified by the Matriptase-Prostasin serine protease cascade in cultured epithelial cells. Biochim Biophys Acta. 2008;1783:896-903.
21. Laribi A, Berteau P, Gala J, Eschwège P, Benoit G, Tombal B. Blood- borne RT-PCR assay for prostasin- specific transcripts to identify circulating prostate cells in cancer patients. Eur Urol. 2001;39:65-71.